Primary Recipient

UNIVERSITY OF WASHINGTON

Amount

$953,661.00

Award Date

9/28/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Adjuvant endocrine therapy improves outcomes for estrogen receptor positive (ER+) early stage breast cancer. Recently aromatase inhibitors (AIs) have been shown to provide incremental benefit over tamoxifen. In neoadjuvant endocrine therapy studies, a t

Recipients Connected to Award

Recipient	Role	Amount
UNIVERSITY OF WASHINGTON	Primary recipient	$616,988.00
FRED HUTCHINSON CANCER RESEARCH CENTER	Sub-recipient	$315,733.00
FRED HUTCHINSON CANCER RESEARCH CENTER	Sub-recipient	$20,940.00